)
Mouwasat Medical Services Company (4002) investor relations material
Mouwasat Medical Services Company Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Revenue for the six months ended 30 June 2026 reached SR 1.71 billion, up from SR 1.56 billion year-over-year, driven by growth in both medical services and pharmaceutical sales.
Net profit attributable to shareholders for the six-month period was SR 412.4 million, compared to SR 384.0 million in the prior year.
The Yanbu hospital commenced operations in February 2026, transferring SR 407.9 million from construction in progress to property and equipment.
Financial highlights
Gross profit for the six-month period was SR 699.4 million, up from SR 674.8 million year-over-year.
Basic and diluted EPS for the six months was SR 2.06, compared to SR 1.92 in the prior year.
Total assets increased to SR 6.62 billion as of 30 June 2026, from SR 5.99 billion at year-end 2025.
Cash and cash equivalents at period end were SR 159.0 million, down from SR 497.5 million at year-end 2025.
Dividends of SR 225 million were paid to shareholders during the period.
Outlook and guidance
The Group is assessing the impact of IFRS 18, which will affect the structure of the statement of profit or loss starting 2027.
Capital commitments for expansion projects total SR 370.87 million as of 30 June 2026.
- Q1 2026 revenue rose 9.1% and net profit 2.3%, driven by medical and pharma segment growth.4002
Q1 2026 - Net profit jumped 27.2% to SAR 822 million on 12% revenue growth and robust operational expansion.4002
Q4 2025 - Strong revenue and profit growth supported by expansion and robust segment performance.4002
Q3 2025 - Net profit and revenue increased year-over-year, supported by robust medical and pharmaceutical growth.4002
Q2 2025 - Revenue and net profit increased, supported by robust medical and pharmaceutical operations.4002
Q2 2024 - Revenue and net profit rose, with strong cash flow and strategic capital moves in 2024.4002
Q3 2024 - Revenue up 6.4% to SAR 2,879m, net profit down 1.8% to SAR 646m, SAR 400m dividend proposed.4002
Q4 2024 - Net profit rose 14.8% on 5.7% revenue growth, with strong cash flow and continued expansion.4002
Q1 2025
Next Mouwasat Medical Services Company earnings date
Next Mouwasat Medical Services Company earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)